Part ofopioid epidemic →

FEDERALhearing transcript

High Impact

Congressional Hearing: DHS Efforts to Combat the Opioid Epidemic

Original title: EXAMINING DHS'S EFFORTS TO COMBAT THE OPIOID EPIDEMIC

January 1, 2022

opioid epidemic border security homeland security drug trafficking public health

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

The Frame

What this does

This hearing establishes the oversight record for how federal agencies allocate resources and intelligence to intercept illicit opioids at the border, directly impacting national drug enforcement strategies and public health policy.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

Department of Homeland Security

The agency is subject to congressional oversight regarding its operational strategies and resource allocation for drug interdiction.

General Public

The public is affected by the federal government's success or failure in preventing illicit opioids from entering the country.

What changed

Last recorded activity January 1, 2022.

What's next

Next step not available in the current record.

Summary

The House Subcommittee on Border Security, Facilitation, and Operations held a hearing on May 18, 2022, to review how the Department of Homeland Security (DHS) is addressing the national opioid crisis. The session featured testimony from DHS officials regarding border and intelligence strategies in response to record-high overdose deaths.

Key Facts

The hearing took place on May 18, 2022, in the Cannon House Office Building.
CDC data cited in the hearing indicates over 107,000 drug overdose deaths occurred in the U.S. in 2021.
The hearing focused on the role of DHS, specifically Customs and Border Protection (CBP) and Immigration and Customs Enforcement (ICE), in combating the opioid epidemic.
Witnesses included representatives from the Transnational Organized Crime Mission Center, the Office of Field Operations, and Homeland Security Investigations.
The subcommittee requested follow-up information from witnesses Brian Sulc, Pete Flores, and Steve Cagan for the official record.

Frequently Asked Questions

What was the purpose of this hearing?

To examine the Department of Homeland Security's strategies and efforts to combat the opioid epidemic, particularly regarding border security and drug .

Who testified at the hearing?

Officials from the DHS Office of Intelligence & Analysis, U.S. Customs & Border Protection, and U.S. Immigration & Customs Enforcement.

Why It Matters

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift90% confidence

Focus on Transnational Crime

The hearing highlights a shift toward treating the opioid epidemic as a transnational organized crime issue rather than solely a public health or border enforcement issue.

Department of Homeland Security Transnational Organized Crime Mission Center

Connected Entities

personNanette Diaz Barragan“Chairwoman of the Subcommittee on Border Security, Facilitation, and Operations”Map →

personPete Flores“Executive Assistant Commissioner, Office of Field Operations, CBP”Map →

organizationCenters for Disease Control and Prevention“Source of overdose death statistics”Map →

personBrian Sulc“Executive Director, Transnational Organized Crime Mission Center, DHS”Map →

personClay Higgins“Ranking Member of the Subcommittee”Map →

organizationDepartment of Homeland Security“Primary federal department under review”Map →

personSteven W. Cagan“Assistant Director for Countering Transnational Organized Crime, ICE”Map →

Sources

Open source document

www.govinfo.gov

Analysis Score

0–100

Significance75
How much this matters to a regular citizen
Controversy40
Intensity of disagreement among stakeholders
Entertainment10
Compellingness for a non-policy-wonk reader
Buzz20
Current news / social attention level

Publisher tools